Stock vs Stock Comparison

Humana Inc. vs Absci Corporation

HUM wins the Tale of the Tape 6–3.

HUM$327.54
ABSI$5.94

🏆 Tale of the Tape

63
HUMABSI
0.9%Profitability (Net Margin)-4113.7%
32.6xValuation (P/E)
3.5%Efficiency (ROIC)-46.9%
3/9Health (Piotroski F)2/9
4.1Safety (Altman Z)5.1
10.1%Growth (Rev YoY)-38.2%
-0.57Risk (Sharpe 1Y)0.56
1.76xBalance Sheet (D/E)0.14x
1.20%FCF Yield-21.57%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.056
252-Day Correlation
0.071
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricHUMABSI
Market Cap$36.7B$1.1B
P/E Ratio32.6x
Forward P/E19.6x-10.6x
P/B1.97x6.10x
Dividend Yield1.16%
Beta0.682.38

Quantitative Metrics

MetricHUMABSI
DCF Fair Value
DCF Upside
Piotroski F3/92/9
Altman Z4.085.11
Beneish M
FCF Yield1.20%-21.57%
Net Debt/EBITDA2.7x
ROIC3.5%-46.9%
WACC6.6%
ROIC – WACC-3.1pp
Gross Margin
Net Margin0.9%-4113.7%
Rev Growth YoY10.1%-38.2%
Sharpe (1Y)-0.570.56
Max Drawdown 3Y-66.1%
FCF Payout Ratio115%

HUM Price

Loading chart...

ABSI Price

Loading chart...

ETF Exposure

HUM found in:

XHS3.19%
ONEV1.08%
ONEY0.91%
XLV0.68%
VOE0.51%
VHT0.46%
ONEO0.42%
VO0.29%
RSP0.15%
VFVA0.13%
SPYV0.13%
VYM0.12%
VTV0.11%
QUS0.10%
VONV0.09%
SCHG0.09%
IWD0.07%
SPLG0.06%
SPY0.06%
SPTM0.06%
IVV0.05%
VOO0.05%
ITOT0.05%
ESGV0.04%
VTI0.04%
VONE0.04%
SCHX0.04%
SCHB0.03%
URTH0.03%
ACWI0.02%
GWX0.01%

ABSI found in:

ARKG4.81%
XBI0.32%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

HUM vs ABSI: Head-to-Head Analysis

Humana Inc. (HUM) and Absci Corporation (ABSI) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, HUM leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, HUM generates a return on invested capital (ROIC) of 3.5% compared to ABSI's -46.9%. This suggests HUM is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between HUM and ABSI is 0.056, indicating low correlation, making them an effective diversification pair in a portfolio context.

HUM appears in 31 ETFs tracked by SecuritiesDB, while ABSI appears in 2 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, HUM or ABSI?

Our quantitative analysis compares HUM and ABSI across nine fundamental dimensions. HUM wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are HUM and ABSI correlated?

The 252-day correlation between HUM and ABSI is 0.056. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.